Products for Research Use Only
RegisterLogin

LDN-214117

CAT: 0013-GTR19173337-01Size: 2 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19173337-01Size:2 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
LDN-214117 is a selective small molecule inhibitor targeting the ALK2 kinase. It is utilized in research to investigate pathways involving bone morphogenetic proteins (BMPs), with applications in both cellular studies and animal models of fibrodysplasia ossificans progressiva (FOP) and other disorders.
CAS Number
1627503-67-6
Product Name Alternative
ALK3, ALK2, ALK5, ALK1, bone morphogenetic proteins (BMPs), BMP6, BMP4, BMP2, diffuse intrinsic pontine glioma (DIPG), oral, fibrodysplasia ossificans progressiva (FOP), LDN 214117, LDN214117, LDN-214117, Transforming growth factor beta receptors, TGFβ, TGFbeta/Smad, TGF-β Receptor, TGF-β/Smad, TGF-b/Smad, TGFb, TGFbeta, TGF-beta, Smad, type I receptor kinases
Field of Research
Cardiovascular Research, Signal Transduction, Stem Cell & Developmental Biology
Purity
98.00% (May vary between batches)
Solubility
DMSO:4.2 mg/mL (10.01 mM) ; Ethanol:42 mg/mL (100.11 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.38 mM)
Smiles
COc1cc (cc (OC) c1OC) -c1cc (cnc1C) -c1ccc (cc1) N1CCNCC1
Molecular Formula
C25H29N3O3
Molecular Weight
419.52
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19174358-01LDN-212320
GTR19166287-01LDN-192960
GTR19200005-01LDN-209929
GTR19199029-01LDN-193665
GTR19191024-01LDN-0088050
GTR19177161-01LDN-27219
GTR19173141-01LDN-212854
GTR19317204-01LDN-211904
GTR19258858-01LDN 193688
GTR19156785-01LDN-27219

Alternative Products

CatalogName
B4842-5LDN-214117
CQC50367-01LDN 214117
A16096-25LDN-214117 25mg

Popular Products